Verastem (VSTM)
(Delayed Data from NSDQ)
$2.96 USD
-0.01 (-0.34%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $2.97 +0.01 (0.34%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
Verastem, Inc. [VSTM]
Reports for Purchase
Showing records 41 - 60 ( 266 total )
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 12122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 112122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 111122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Continued Clinical Progress Into 2023; Adjust PT to $3; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 11122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 102122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 101122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 10122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Minimal Impact Expected From Copiktra AdCom Decision; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 92122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 91122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 9122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 82122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 81122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Looking Ahead to Results From RAMP 202 and 203 Studies; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: LEE S
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 8122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 72122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 71122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Verastem, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VSTM 62122
Provider: Stock Traders Daily
Analyst: Research Department